Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Current Deferred Revenue (2021 - 2025)

Medicinova (MNOV) has disclosed Current Deferred Revenue for 2 consecutive years, with $370160.0 as the latest value for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue changed N/A to $370160.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $370160.0, a N/A change, with the full-year FY2025 number at $370160.0, changed N/A from a year prior.
  • Current Deferred Revenue was $370160.0 for Q4 2025 at Medicinova, down from $521899.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $1.7 million in Q3 2021 to a low of $370160.0 in Q4 2025.